Fulgent Genetics (FLGT) EBITDA Margin Growth (3y) (2018 - 2026)
Fulgent Genetics (FLGT) EBITDA Margin Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 263.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -168.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 360.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -56.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -247.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 4,378.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 2,862.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 146.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 20.00 |
| 10 | Fulgent Genetics | 518.37 Mn | 261.34 Mn | 25.68 Mn | -1,307.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,307.00 |
| Mar 31, 2026 | -1,115.00 |
| Dec 31, 2025 | -14,533.00 |
| Sep 30, 2025 | -1,859.00 |
| Jun 30, 2025 | -3,431.00 |
| Mar 31, 2025 | -9,000.00 |
| Dec 31, 2024 | -8,111.00 |
| Sep 30, 2024 | -9,370.00 |
| Jun 30, 2024 | -9,100.00 |
| Mar 31, 2024 | -10,807.00 |
| Dec 31, 2023 | -29,093.00 |
| Sep 30, 2023 | -6,220.00 |
| Jun 30, 2023 | -4,447.00 |
| Mar 31, 2023 | -1,283.00 |
| Dec 31, 2022 | 2,521.00 |
| Sep 30, 2022 | -1,425.00 |
| Jun 30, 2022 | 671.00 |
| Mar 31, 2022 | 9,700.00 |
| Dec 31, 2021 | 7,808.00 |
| Sep 30, 2021 | 8,494.00 |